Get the Latest Investment Ideas Delivered Straight to Your Inbox. Subscribe

TICKERS: XBRAF

Outlook for Mexican Cannabis Stock Is Strong
Contributed Opinion

Share on Stocktwits

Source:

While short-term speculators have done well, a favorable Supreme Court judgment affords a huge competitive advantage for Mexican cannabis company XEBRA Brands Ltd. over the next two or three years.

While we could have got out at an even higher level two days later if we had moved fast, we still did well with this, tripling our money in a week, for it did as expected, reacting back hard on good news as speculators booked profits. That included us, although we got out a shade early.

The news when it came out was very good indeed as a favorable Supreme Court judgment affords XEBRA Brands Ltd. (XBRAF) a huge competitive advantage for the next two or three years.

Looking at the latest six-month chart, we can see our entry and exit points and how the stock reacted back hard on the news. But notice how volume dropped right back on this reaction, which has brought it back to a zone of quite strong support above the earlier saucer-like base that preceded the advance.

This volume dieback is bullish so it looks like it will soon start again. Hardly surprising given the positive outlook for the company.

XEBRA is therefore rated an immediate speculative buyback. Keep in mind though that anything can happen with these smaller speculative stocks, so don’t go "betting the farm" on it.

XEBRA Brands Ltd. closed at CA$0.31 on Dec. 8, 2021.

Clive Maund has been president of www.clivemaund.com, a successful resource sector website, since its inception in 2003. He has 30 years' experience in technical analysis and has worked for banks, commodity brokers and stockbrokers in the City of London. He holds a Diploma in Technical Analysis from the UK Society of Technical Analysts.

[NLINSERT]

Disclosure:
1) Statements and opinions expressed are the opinions of Clive Maund and not of Streetwise Reports or its officers. Clive Maund is wholly responsible for the validity of the statements. Streetwise Reports was not involved in the content preparation. Clive Maund was not paid by Streetwise Reports LLC for this article. Streetwise Reports was not paid by the author to publish or syndicate this article. Additional Clive Maund disclosures are listed below.

2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.

3) This article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.

4) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the decision to publish an article until three business days after the publication of the article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) do not own securities of XEBRA Brands Ltd., a company mentioned in this article.

Charts provided by the author.

CliveMaund.com Disclosures:
The above represents the opinion and analysis of Mr Maund, based on data available to him, at the time of writing. Mr. Maund's opinions are his own, and are not a recommendation or an offer to buy or sell securities. Mr. Maund is an independent analyst who receives no compensation of any kind from any groups, individuals or corporations mentioned in his reports. As trading and investing in any financial markets may involve serious risk of loss, Mr. Maund recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction and do your own due diligence and research when making any kind of a transaction with financial ramifications. Although a qualified and experienced stock market analyst, Clive Maund is not a Registered Securities Advisor. Therefore Mr. Maund's opinions on the market and stocks can only be construed as a solicitation to buy and sell securities when they are subject to the prior approval and endorsement of a Registered Securities Advisor operating in accordance with the appropriate regulations in your area of jurisdiction.




Want to read more about Cannabis investment ideas?
Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe